vs

Side-by-side financial comparison of FIRST MERCHANTS CORP (FRME) and Vertex, Inc. (VERX). Click either name above to swap in a different company.

Vertex, Inc. is the larger business by last-quarter revenue ($196.6M vs $157.1M, roughly 1.3× FIRST MERCHANTS CORP). FIRST MERCHANTS CORP runs the higher net margin — 17.9% vs -1.3%, a 19.2% gap on every dollar of revenue. Over the past eight quarters, Vertex, Inc.'s revenue compounded faster (10.5% CAGR vs -0.9%).

First Merchants Corporation is a financial holding company in Central Indiana, headquartered in Muncie, Indiana. The Corporation includes First Merchants Bank and First Merchants Private Wealth Advisors. The company is listed on the NASDAQ as FRME. As of March 2023, total asset size of First Merchants Corporation was $18.2 billion. First Merchants offers commercial banking, personal banking, and investment advisor services.

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

FRME vs VERX — Head-to-Head

Bigger by revenue
VERX
VERX
1.3× larger
VERX
$196.6M
$157.1M
FRME
Higher net margin
FRME
FRME
19.2% more per $
FRME
17.9%
-1.3%
VERX
Faster 2-yr revenue CAGR
VERX
VERX
Annualised
VERX
10.5%
-0.9%
FRME

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
FRME
FRME
VERX
VERX
Revenue
$157.1M
$196.6M
Net Profit
$28.2M
$-2.5M
Gross Margin
63.5%
Operating Margin
31.1%
Net Margin
17.9%
-1.3%
Revenue YoY
11.1%
Net Profit YoY
-49.1%
-122.6%
EPS (diluted)
$0.45
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRME
FRME
VERX
VERX
Q1 26
$157.1M
$196.6M
Q4 25
$172.2M
$194.7M
Q3 25
$166.1M
$192.1M
Q2 25
$164.3M
$184.6M
Q1 25
$160.3M
$177.1M
Q4 24
$177.1M
$178.5M
Q3 24
$156.0M
$170.4M
Q2 24
$159.9M
$161.1M
Net Profit
FRME
FRME
VERX
VERX
Q1 26
$28.2M
$-2.5M
Q4 25
$57.1M
$-7.0M
Q3 25
$56.8M
$4.0M
Q2 25
$56.8M
$-961.0K
Q1 25
$55.3M
$11.1M
Q4 24
$64.3M
$-67.8M
Q3 24
$49.2M
$7.2M
Q2 24
$39.9M
$5.2M
Gross Margin
FRME
FRME
VERX
VERX
Q1 26
63.5%
Q4 25
64.8%
Q3 25
63.1%
Q2 25
65.7%
Q1 25
63.8%
Q4 24
65.6%
Q3 24
64.8%
Q2 24
63.7%
Operating Margin
FRME
FRME
VERX
VERX
Q1 26
31.1%
Q4 25
38.0%
-1.3%
Q3 25
39.3%
2.2%
Q2 25
39.6%
-2.1%
Q1 25
39.4%
2.5%
Q4 24
43.3%
-7.3%
Q3 24
36.1%
2.9%
Q2 24
27.5%
4.7%
Net Margin
FRME
FRME
VERX
VERX
Q1 26
17.9%
-1.3%
Q4 25
33.1%
-3.6%
Q3 25
34.2%
2.1%
Q2 25
34.6%
-0.5%
Q1 25
34.5%
6.3%
Q4 24
36.3%
-38.0%
Q3 24
31.5%
4.2%
Q2 24
25.0%
3.2%
EPS (diluted)
FRME
FRME
VERX
VERX
Q1 26
$0.45
$-0.02
Q4 25
$0.98
Q3 25
$0.98
Q2 25
$0.98
Q1 25
$0.94
Q4 24
$1.09
Q3 24
$0.84
Q2 24
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRME
FRME
VERX
VERX
Cash + ST InvestmentsLiquidity on hand
$252.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$246.5M
Total Assets
$21.1B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRME
FRME
VERX
VERX
Q1 26
$252.5M
Q4 25
$314.0M
Q3 25
$313.5M
Q2 25
$284.4M
Q1 25
$270.4M
Q4 24
$296.1M
Q3 24
$279.0M
Q2 24
$325.5M
Total Debt
FRME
FRME
VERX
VERX
Q1 26
Q4 25
$337.5M
Q3 25
$336.9M
Q2 25
$336.3M
Q1 25
$335.8M
Q4 24
$335.2M
Q3 24
$334.7M
Q2 24
$334.1M
Stockholders' Equity
FRME
FRME
VERX
VERX
Q1 26
$2.7B
$246.5M
Q4 25
$2.5B
$258.9M
Q3 25
$2.4B
$264.5M
Q2 25
$2.3B
$248.0M
Q1 25
$2.3B
$200.5M
Q4 24
$2.3B
$179.4M
Q3 24
$2.3B
$259.0M
Q2 24
$2.2B
$233.1M
Total Assets
FRME
FRME
VERX
VERX
Q1 26
$21.1B
$1.2B
Q4 25
$19.0B
$1.3B
Q3 25
$18.8B
$1.2B
Q2 25
$18.6B
$1.2B
Q1 25
$18.4B
$1.2B
Q4 24
$18.3B
$1.2B
Q3 24
$18.3B
$1.2B
Q2 24
$18.3B
$1.0B
Debt / Equity
FRME
FRME
VERX
VERX
Q1 26
Q4 25
1.30×
Q3 25
1.27×
Q2 25
1.36×
Q1 25
1.67×
Q4 24
1.87×
Q3 24
1.29×
Q2 24
1.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRME
FRME
VERX
VERX
Operating Cash FlowLast quarter
$38.0M
Free Cash FlowOCF − Capex
$7.7M
FCF MarginFCF / Revenue
3.9%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRME
FRME
VERX
VERX
Q1 26
$38.0M
Q4 25
$283.6M
$42.3M
Q3 25
$87.6M
$62.5M
Q2 25
$53.7M
$46.0M
Q1 25
$61.7M
$14.8M
Q4 24
$266.2M
$41.1M
Q3 24
$76.8M
$41.4M
Q2 24
$63.0M
$57.7M
Free Cash Flow
FRME
FRME
VERX
VERX
Q1 26
$7.7M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$-24.3M
Q2 24
FCF Margin
FRME
FRME
VERX
VERX
Q1 26
3.9%
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-14.2%
Q2 24
Capex Intensity
FRME
FRME
VERX
VERX
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
38.5%
Q2 24
Cash Conversion
FRME
FRME
VERX
VERX
Q1 26
Q4 25
4.97×
Q3 25
1.54×
15.44×
Q2 25
0.94×
Q1 25
1.11×
1.33×
Q4 24
4.14×
Q3 24
1.56×
5.73×
Q2 24
1.58×
11.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FRME
FRME

Net Interest Income$151.3M96%
Noninterest Income$5.8M4%

VERX
VERX

Software subscriptions$167.1M85%
Services$29.5M15%

Related Comparisons